For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Apotex Technologies Inc.

USPTO Granted Patents = 13

% Expired Patents = 69.2

CIPO Patents = 2

EPO Patents = 4

Trademarks = 13

Forward Citations = 16

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Tim Fat Tam (12 out of 33 patents)

Yingsheng Wang (12 out of 17 patents)

Yanqing Zhao (12 out of 17 patents)

4. Regis C Leung-Toung (11 out of 19 patents)

5. Blaise N'Zemba (9 out of 10 patents)

6. Lily Yu (8 out of 9 patents)

7. Jolanta Maria Wodzinska (2 out of 4 patents)

8. Maryna Premyslova (2 out of 2 patents)

9. Tao Xin (2 out of 29 patents)

10. Birenkumar Hasmukhbhai Shah (2 out of 6 patents)

11. Michael Spino (1 out of 11 patents)

12. Anita Hui (1 out of 1 patent)

13. Cihua Yang (1 out of 1 patent)

14. Mohammed N Kabir (1 out of 1 patent)

15. Blaise N′Zemba (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 9550733 - Fluorinated derivatives of 3-hydroxypyridin-4-ones (2017-01-24),

2. 9073865 - Fluorinated derivates of 3-hydroxypyridin-4-ones (2015-07-07),

3. 8735602 - Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture (2014-05-27),

4. 8703156 - Liquid formulation for deferiprone with palatable taste (2014-04-22),

5. 8673943 - Fluorinated derivatives of deferiprone (2014-03-18),

6. 8664262 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2014-03-04),

7. 8592607 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2013-11-26),

8. 8507449 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2013-08-13),

9. 8481588 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2013-07-09),

10. 8476235 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2013-07-02),

11. 8207217 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2012-06-26),

12. 8119606 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2012-02-21),

13. 8026261 - Fluorinated derivatives of deferiprone (2011-09-27),

Apotex Technologies Inc., based in Toronto, Canada, is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of generic medications. The company focuses on delivering high-quality, affordable alternatives to branded drugs, thereby enhancing patient access to essential therapies. With a commitment to innovation, Apotex invests in research and development across various therapeutic areas, ensuring a robust pipeline of products that meet global healthcare needs.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#118 in Toronto

#1,161 in Canada

#44,988 in the World

Toronto, Canada

Apotex Technologies Inc.

Forward Citations = 16

16 inventors:

Tim Fat Tam (12 out of 33 patents)

Yingsheng Wang (12 out of 17 patents)

Yanqing Zhao (12 out of 17 patents)

4. Regis C Leung-Toung (11 out of 19 patents)

5. Blaise N'Zemba (9 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…